Today's Top Performers In Health Services

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 11 points (0.1%) at 16,218 as of Tuesday, Feb. 25, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,600 issues advancing vs. 1,298 declining with 186 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Agilent Technologies ( A), up 1.2%. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 8.0%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 5.4%, Community Health Systems ( CYH), down 3.9%, ResMed ( RMD), down 2.9% and DaVita HealthCare Partners ( DVA), down 1.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Catamaran ( CTRX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Catamaran is up $1.08 (2.1%) to $52.49 on average volume. Thus far, 785,109 shares of Catamaran exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $51.35-$52.73 after having opened the day at $51.72 as compared to the previous trading day's close of $51.41.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $10.5 billion and is part of the health care sector. Shares are up 7.7% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Catamaran a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Boston Scientific ( BSX) is up $0.28 (2.2%) to $13.36 on average volume. Thus far, 5.7 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.8 million shares. The stock has ranged in price between $13.05-$13.45 after having opened the day at $13.09 as compared to the previous trading day's close of $13.08.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.5 billion and is part of the health care sector. Shares are up 8.8% year-to-date as of the close of trading on Monday. Currently there are 8 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Thermo Fisher Scientific ( TMO) is up $0.76 (0.6%) to $124.13 on average volume. Thus far, 1.1 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $123.09-$124.30 after having opened the day at $123.56 as compared to the previous trading day's close of $123.37.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $44.5 billion and is part of the health care sector. Shares are up 10.8% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Thermo Fisher Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers